Evidence map›Paper›PMID 27673420›Full record

ReviewPediatric research2017

Therapeutic hypothermia translates from ancient history in to practice.

Alistair J Gunn, Abbot R Laptook, Nicola J Robertson, John D Barks, Marianne Thoresen, Guido Wassink, Laura Bennet

Open access · bronzeAbstract readHistorical ArticleReview
In one paragraph

Review in Pediatric research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 5 pooled it
24.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 5 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia.Annals of clinical and translational neurology · 2022
    Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Comparison of the prognosis of asphyxiated infants receiving hypothermia therapy with those receiving erythropoietin: a prospective cohort study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Alistair J GunnDepartment of Physiology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
Abbot R LaptookDepartment of Neonatology, Warren Alpert Medical School, Brown University, Women & Infants Hospital, Providence, Rhode Island.
Nicola J RobertsonInstitute for Women's Health, University College London, London, UK.
John D BarksDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan.
Marianne ThoresenNeonatal Neuroscience, School of Clinical Sciences, University of Bristol, Bristol, UK.
Guido WassinkDepartment of Physiology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
Laura BennetDepartment of Physiology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
University of Auckland · NZBrown University · USUniversity College London · GBUniversity of Bristol · GBUniversity of Michigan–Ann Arbor · US

Funding

NICHD Neonatal Research NetworkUG1HD027904 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI MARON, JILL LAMANNA · 2016 to 2024
$2.1M
NICHD NIH HHS UG1 HD027904
6 · The paper itself

Abstract

Acute postasphyxial encephalopathy around the time of birth remains a major cause of death and disability. The possibility that hypothermia may be able to prevent or lessen asphyxial brain injury is a "dream revisited". In this review, a historical perspective is provided from the first reported use of therapeutic hypothermia for brain injuries in antiquity, to the present day. The first uncontrolled trials of cooling for resuscitation were reported more than 50 y ago. The seminal insight that led to the modern revival of studies of neuroprotection was that after profound asphyxia, many brain cells show initial recovery from the insult during a short "latent" phase, typically lasting ~6 h, only to die hours to days later during a "secondary" deterioration phase characterized by seizures, cytotoxic edema, and progressive failure of cerebral oxidative metabolism. Studies designed around this conceptual framework showed that mild hypothermia initiated as early as possible before the onset of secondary deterioration, and continued for a sufficient duration to allow the secondary deterioration to resolve, is associated with potent, long-lasting neuroprotection. There is now compelling evidence from randomized controlled trials that mild induced hypothermia significantly improves intact survival and neurodevelopmental outcomes to midchildhood.

Indexed as

AnimalsAsphyxiaAsphyxia NeonatorumBrain InjuriesHistory, 20th CenturyHistory, AncientHumansHypothermia, InducedHypoxia-Ischemia, BrainInfant, NewbornNeuroprotectionRandomized Controlled Trials as TopicSeizures

Identifiers

PMID27673420
PMCPMC5233584
OpenAlexW2524741614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.